Phosphatidyl Choline
Phosphatidyl Choline from Thorne Research is a vitamin and mineral supplement, specifically a fat/fatty acid product, with 100% label transparency. It achieved an N+ Score of 65, earning a 'D' grade, indicating an average tier product. The primary active ingredient, Phosphatidylcholine, is provided at a clinical dose of 420mg per softgel, which research suggests may support cellular health and cognitive functions. As a single-ingredient focus product, its formula completeness is not a primary factor, but its ingredient adequacy is rated at 100% for its chosen component. This supplement is suitable for individuals specifically looking to supplement with a clinically dosed amount of Phosphatidylcholine.
About This Product
Phosphatidyl Choline by Thorne Research is a vitamins & minerals supplement containing 3 active ingredients. It has earned an N+ Score of 65/100 (Grade D).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Phosphatidylcholine.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (3 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 5.000 {Calories} | N/A |
| Total Fat | 1.000 g | N/A |
| Phosphatidylcholine | 420.000 mg | Optimal |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.